NantHealth (NH) Misses Q4 EPS by 2c

NantHealth (NASDAQ: NH) reported Q4 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16 million versus the consensus estimate of $16.01 million.

For earnings history and earnings-related data on NantHealth (NH) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy